These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34774101)

  • 1. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits.
    Li MM; Yuan J; Guan XY; Ma NF; Liu M
    Exp Hematol Oncol; 2021 Nov; 10(1):53. PubMed ID: 34774101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncofetal proteins and cancer stem cells.
    Yan Q; Fang X; Li C; Lan P; Guan X
    Essays Biochem; 2022 Sep; 66(4):423-433. PubMed ID: 35670043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
    Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtypes in cancers of the gastrointestinal tract.
    Bijlsma MF; Sadanandam A; Tan P; Vermeulen L
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):333-342. PubMed ID: 28400627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.
    Shibata M; Hoque MO
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in human gastrointestinal cancer.
    Taniguchi H; Moriya C; Igarashi H; Saitoh A; Yamamoto H; Adachi Y; Imai K
    Cancer Sci; 2016 Nov; 107(11):1556-1562. PubMed ID: 27575869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
    De Francesco EM; Sotgia F; Lisanti MP
    Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
    Marquardt JU; Raggi C; Andersen JB; Seo D; Avital I; Geller D; Lee YH; Kitade M; Holczbauer A; Gillen MC; Conner EA; Factor VM; Thorgeirsson SS
    Hepatology; 2011 Sep; 54(3):1031-42. PubMed ID: 21618577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits.
    Warrier S; Patil M; Bhansali S; Varier L; Sethi G
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188475. PubMed ID: 33188876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.
    Ahmad R; Dhawan P; Singh AB
    Biochem Pharmacol (Los Angel); 2016; 5(2):. PubMed ID: 31656694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers.
    Gramantieri L; Giovannini C; Suzzi F; Leoni I; Fornari F
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of cancer stem cells and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking inhibition of tumorigenesis and the potential eradication of HIV-1.
    Finley J
    Med Hypotheses; 2017 Jul; 104():133-146. PubMed ID: 28673572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method to Convert Stem Cells into Cancer Stem Cells.
    Afify SM; Chen L; Yan T; Calle AS; Nair N; Murakami C; Zahra MH; Okada N; Iwasaki Y; Seno A; Seno M
    Methods Protoc; 2019 Aug; 2(3):. PubMed ID: 31426391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic subtyping of gastrointestinal malignancies.
    de Back TR; van Hooff SR; Sommeijer DW; Vermeulen L
    Trends Cancer; 2024 Jul; ():. PubMed ID: 39019673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.